about
An "escape clock" for estimating the turnover of SIV DNA in resting CD4⁺ T cellsThrombocytopenia is strongly associated with simian AIDS in pigtail macaques.Complexity of the inoculum determines the rate of reversion of SIV Gag CD8 T cell mutant virus and outcome of infection.Timing of immune escape linked to success or failure of vaccination.Comparison of influenza and SIV specific CD8 T cell responses in macaquesMeasuring turnover of SIV DNA in resting CD4+ T cells using pyrosequencing: implications for the timing of HIV eradication therapiesRisk of colorectal cancer for people with a mutation in both a MUTYH and a DNA mismatch repair gene.Childhood cancers in families with and without Lynch syndrome.Trivalent live attenuated influenza-simian immunodeficiency virus vaccines: efficacy and evolution of cytotoxic T lymphocyte escape in macaques.Evaluation of recombinant influenza virus-simian immunodeficiency virus vaccines in macaques.The search for an HIV cure: tackling latent infection.Family history and risk of endometrial cancer: a systematic review and meta-analysis.Risk factors for metachronous colorectal cancer or polyp: A systematic review and meta-analysis.Mould-sensitized adults have lower Th2 cytokines and a higher prevalence of asthma than those sensitized to other aeroallergens.Safety, immunogenicity and efficacy of peptide-pulsed cellular immunotherapy in macaques.Cholecystectomy and the risk of colorectal cancer by tumor mismatch repair deficiency status.Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH.Risk factors for metachronous colorectal cancer following a primary colorectal cancer: A prospective cohort study.Epitope-specific CD8+ T cell kinetics rather than viral variability determine the timing of immune escape in simian immunodeficiency virus infection.Modeling the timing of antilatency drug administration during HIV treatment.Vaccine-induced T cells control reversion of AIDS virus immune escape mutantsEvaluation of recombinant Kunjin replicon SIV vaccines for protective efficacy in macaques.Short communication: characteristics of effective immune control of simian/human immunodeficiency virus in pigtail macaques.Attenuated and wild-type HIV-1 infections and long terminal repeat-mediated gene expression from plasmids delivered by gene gun to human skin ex vivo and macaques in vivo.Correction: An “Escape Clock” for Estimating the Turnover of SIV DNA in Resting CD4+ T Cells.P09-08. The complexity of the infecting inoculum determines the outcome of infection.P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques.The 1998 Lindberg Award. Comparison of glycerol preservation with cryopreservation methods on HIV-1 inactivation.Delivery of immunotherapy with peptide-pulsed blood in macaquesSubtype AE HIV-1 DNA and recombinant Fowlpoxvirus vaccines encoding five shared HIV-1 genes: safety and T cell immunogenicity in macaquesMapping the major human T helper epitopes of tetanus toxin. The emerging pictureNeoadjuvant Chemoradiotherapy and Tumor Recurrence in Patients with Early T-Stage Cancer of the Lower RectumEnd-to-side Somatic-to-autonomic Nerve Grafting to Restore Erectile Function and Improve Quality of Life After Radical Prostatectomy
P50
Q28482134-58F96099-0CD0-41B8-9CC5-27D8BC3B5918Q33384619-49F0BA9B-8C51-4990-8E60-27C0F723DEBCQ33429036-CA0B50A4-1638-4A05-A8A7-C88F450DD12BQ33700493-04965D53-62D8-4B94-9CE9-01CD02D4C745Q33700493-A6EBCD76-D274-4739-82D6-9B08CBD1E585Q34189478-3C65A06E-A49F-4527-B664-0225BE790C8EQ35141776-40A4BD6D-6EBE-4501-9FDB-238F3F56C7EDQ36244730-6BA2586B-01AA-41DD-B834-6A816C28B436Q36244800-D8AC55F9-2A7B-4C8F-81AD-A99F00773744Q36760165-D2326C63-B0FB-44CF-A2F9-BF35A53C9D8EQ37256687-B57A8646-48AC-4CBD-B8AD-608B8EB2BFA8Q38088556-2E2B2748-1E61-41AF-93BE-D11C62B33EA7Q38307884-EE682041-914B-4CF2-A812-0FC21EF5B31DQ38880706-91E5DE54-3C29-48ED-A492-E1EA8222CF4AQ39663124-AE9EBD91-B754-46C3-8832-C50E293D20B2Q40004748-78B673E2-B4F1-4C0C-B0BF-2CA3AE6C9030Q40707751-2171A68B-1932-4C2E-BB44-31A49E944C1BQ40747360-D8E4AF31-8D74-4890-B2A4-B607C67DF00DQ40789385-2A67C816-EF2E-4C52-B075-DCD9AA10B216Q41368316-C738C931-00DB-4866-82EF-0A479A28678CQ41727164-A6861BBB-4AA4-4501-B852-D858646BFD30Q41928777-5129ABC4-7F23-4C5B-BF45-C1F3E90E2B64Q43047002-75E4F752-D587-48BE-A25F-B7C11E101CFCQ45420406-3C61B586-96CD-4585-B643-C8CC9AA8751DQ45879191-BD2E3D0A-048A-42BE-B42E-839031298C32Q46053949-BB7BD9DB-3490-474A-AC0E-8D72B2D6FDBBQ46131862-45731A95-F68F-4917-BF1F-ADD46FE0A9D4Q46426972-13048983-729F-49EC-B5C8-1CDC204EE45DQ48380074-E5BE9D00-6A7D-40CF-A052-0CD4C6F515FFQ62129132-B36A50FB-3083-4737-857D-39D90EEBE758Q62129134-B150C1BE-1852-4F71-9682-A075CD670DF0Q62129145-18A4B3BC-1688-4E52-A237-14491BC70169Q91481298-EBA3762F-24E7-4785-B466-F3CAE3A4C292Q92905868-76769E44-5EF7-464D-A655-984A31F5B18D
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jeanette C. Reece
@ast
Jeanette C. Reece
@en
Jeanette C. Reece
@es
Jeanette C. Reece
@nl
Jeanette C. Reece
@sl
type
label
Jeanette C. Reece
@ast
Jeanette C. Reece
@en
Jeanette C. Reece
@es
Jeanette C. Reece
@nl
Jeanette C. Reece
@sl
prefLabel
Jeanette C. Reece
@ast
Jeanette C. Reece
@en
Jeanette C. Reece
@es
Jeanette C. Reece
@nl
Jeanette C. Reece
@sl
P108
P106
P1153
7003294881
P21
P31
P496
0000-0003-2897-0271